| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Couling John D | SVP, Entertainment | C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO | /s/ Daniel Rodriguez as Attorney-in-Fact for John Couling | 24 Nov 2025 | 0001894052 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DLB | Class A Common Stock | Sale | $407,564 | -6,164 | -5.1% | $66.12 | 115,338 | 20 Nov 2025 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Shares held following the reported transaction includes 48,526 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |
| F2 | Shares include 284 shares and 67 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025 and November 17, 2025, respectively. |